That information is very old. And a good example of one of the catastrophic agreements of the past. The deal with Miller appears to have ended in some acrimony, with Blezard explaining that due to 'a lack of support' from the American distributor, sales were abysmal. We no longer trade in America now that Blezard has been binned.
David Dent considers Plant Impact, which is listed on the AIM market of the London Stock Exchange, to be foremost among the companies pursuing what he describes as the “third way” – a combination of ‘green chemistry’ and intelligent design solutions. One of the products developed by David Marks, Chief Technical Officer at Plant Impact, Bug Oil®, is described by Dent as “a brilliantly simple product based on three essential oils working in synergy to provide a very effective preventative and curative pesticide”. Plant Impact recently signed a deal with DVA Agro GmbH for distribution of BugOil® as Bionic™, specifically for ornamental rose production in Tanzania.
Other innovative products include InCa, a plant supplement which improves crop product quality by combining a calcium salt with an auxin mimic to ensure the calcium arrives at the part of the plant which needs it most. InCa offers improved fruit quality, longer shelf life and resistance to climate stress. Plant Impact has signed a five year agreement with US based Miller Chemical & Fertilizer Corporation for the distribution of three products including InCa. Field trials on InCa, in conjunction with Miller, have demonstrated significant advantages in fruit crops, notably apples and pears. A Miller field trial, the first field trial conducted using InCa on arable crops, demonstrated a reduction in the negative effects of drought stress on soya crop by increasing the yield by 17.5%, from 2.69 tonnes/hectare to 3.16 tonnes/hectare.
According to Dent, Plant Impact’s products “owe their success more to understanding the market need and designing products from basic principles to meet that need as opposed to seeking a magic bullet molecule”.
Distribution deals are all well and good but it's SALES we need. Obviously sales tend to follow on from distribution deals but not always is this the case. Especially here, there have been a good number of distribution deals in the past that have spectactularly failed. The market will be very wary of any distribution deals. I would say that PIM realise this as the last couple have been agreed without any accompanying RNS.
I believe it will be distribution news. Mu understanding is that the Arysta connection will underpin this and that Bug Oil will indeed be a viable product. I think the main reason the market did not react is that the last RNS was only part of the jigsaw.
Mr Tea, what good news might that be then? I take it you are not referring to the news that bugoil registration in the US is about to be granted? Because if you read the last notification you will see that it has already been granted, subject to any comments from the general public over a 30 day notice period. The reason the share price has not reacted as it well might have done is because the rights owners appear not to want to do anything with it now, after having waited for over 2 years. The price is depressed because there is still a big question mark over the company's finances. In my view, there is a high rate of cash burn and as yet insufficient generated income.
and how I have been wishing I had sold on the Arysta spike last year. However, things are really falling in place nd this will be back on the radar for a lot of investors. Could be some very good news soon. Se riddler's post for basis of the optimism
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.